Literature DB >> 33468647

Discovery of a hidden transient state in all bromodomain families.

Lluís Raich1, Katharina Meier2, Judith Günther3, Clara D Christ3, Frank Noé4,5, Simon Olsson4.   

Abstract

Bromodomains (BDs) are small protein modules that interact with acetylated marks in histones. These posttranslational modifications are pivotal to regulate gene expression, making BDs promising targets to treat several diseases. While the general structure of BDs is well known, their dynamical features and their interplay with other macromolecules are poorly understood, hampering the rational design of potent and selective inhibitors. Here, we combine extensive molecular dynamics simulations, Markov state modeling, and available structural data to reveal a transiently formed state that is conserved across all BD families. It involves the breaking of two backbone hydrogen bonds that anchor the ZA-loop with the αA helix, opening a cryptic pocket that partially occludes the one associated to histone binding. By analyzing more than 1,900 experimental structures, we unveil just two adopting the hidden state, explaining why it has been previously unnoticed and providing direct structural evidence for its existence. Our results suggest that this state is an allosteric regulatory switch for BDs, potentially related to a recently unveiled BD-DNA-binding mode.

Entities:  

Keywords:  Markov models; allosteric effects; bromodomains; cryptic pockets; minor conformational states

Mesh:

Substances:

Year:  2021        PMID: 33468647      PMCID: PMC7848705          DOI: 10.1073/pnas.2017427118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  63 in total

1.  Cooperative Changes in Solvent Exposure Identify Cryptic Pockets, Switches, and Allosteric Coupling.

Authors:  Justin R Porter; Katelyn E Moeder; Carrie A Sibbald; Maxwell I Zimmerman; Kathryn M Hart; Michael J Greenberg; Gregory R Bowman
Journal:  Biophys J       Date:  2019-01-25       Impact factor: 4.033

Review 2.  Bromodomains: a new target class for drug development.

Authors:  Andrea G Cochran; Andrew R Conery; Robert J Sims
Journal:  Nat Rev Drug Discov       Date:  2019-07-04       Impact factor: 84.694

3.  Combining experimental and simulation data of molecular processes via augmented Markov models.

Authors:  Simon Olsson; Hao Wu; Fabian Paul; Cecilia Clementi; Frank Noé
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

4.  The role of protein dynamics in the evolution of new enzyme function.

Authors:  Eleanor Campbell; Miriam Kaltenbach; Galen J Correy; Paul D Carr; Benjamin T Porebski; Emma K Livingstone; Livnat Afriat-Jurnou; Ashley M Buckle; Martin Weik; Florian Hollfelder; Nobuhiko Tokuriki; Colin J Jackson
Journal:  Nat Chem Biol       Date:  2016-09-12       Impact factor: 15.040

5.  Binding hotspots of BAZ2B bromodomain: Histone interaction revealed by solution NMR driven docking.

Authors:  Fleur M Ferguson; David M Dias; João P G L M Rodrigues; Hans Wienk; Rolf Boelens; Alexandre M J J Bonvin; Chris Abell; Alessio Ciulli
Journal:  Biochemistry       Date:  2014-10-15       Impact factor: 3.162

6.  Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2.

Authors:  Guillaume Poncet-Montange; Yanai Zhan; Jennifer P Bardenhagen; Alessia Petrocchi; Elisabetta Leo; Xi Shi; Gilbert R Lee; Paul G Leonard; Mary K Geck Do; Mario G Cardozo; Jannik N Andersen; Wylie S Palmer; Philip Jones; John E Ladbury
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

7.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.

Authors:  James A Maier; Carmenza Martinez; Koushik Kasavajhala; Lauren Wickstrom; Kevin E Hauser; Carlos Simmerling
Journal:  J Chem Theory Comput       Date:  2015-07-23       Impact factor: 6.006

8.  ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression.

Authors:  Hong Wen; Yuanyuan Li; Yuanxin Xi; Shiming Jiang; Sabrina Stratton; Danni Peng; Kaori Tanaka; Yongfeng Ren; Zheng Xia; Jun Wu; Bing Li; Michelle C Barton; Wei Li; Haitao Li; Xiaobing Shi
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

9.  Assessment of enzyme active site positioning and tests of catalytic mechanisms through X-ray-derived conformational ensembles.

Authors:  Filip Yabukarski; Justin T Biel; Margaux M Pinney; Tzanko Doukov; Alexander S Powers; James S Fraser; Daniel Herschlag
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 12.779

10.  Hidden alternative structures of proline isomerase essential for catalysis.

Authors:  James S Fraser; Michael W Clarkson; Sheena C Degnan; Renske Erion; Dorothee Kern; Tom Alber
Journal:  Nature       Date:  2009-12-03       Impact factor: 49.962

View more
  4 in total

1.  Crystal structure of the BAZ2B TAM domain.

Authors:  Yingying Feng; Sizhuo Chen; Mengqi Zhou; Jin Zhang; Jinrong Min; Ke Liu
Journal:  Heliyon       Date:  2022-07-06

2.  Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors.

Authors:  Rezaul Md Karim; Melissa J Bikowitz; Alice Chan; Jin-Yi Zhu; Dylan Grassie; Andreas Becker; Norbert Berndt; Steven Gunawan; Nicholas J Lawrence; Ernst Schönbrunn
Journal:  J Med Chem       Date:  2021-10-28       Impact factor: 8.039

3.  A cryptic pocket in Ebola VP35 allosterically controls RNA binding.

Authors:  Matthew A Cruz; Thomas E Frederick; Upasana L Mallimadugula; Sukrit Singh; Neha Vithani; Maxwell I Zimmerman; Justin R Porter; Katelyn E Moeder; Gaya K Amarasinghe; Gregory R Bowman
Journal:  Nat Commun       Date:  2022-04-27       Impact factor: 17.694

4.  Design and synthesis of a new orthogonally protected glutamic acid analog and its use in the preparation of high affinity polo-like kinase 1 polo-box domain - binding peptide macrocycles.

Authors:  David Hymel; Kohei Tsuji; Robert A Grant; Ramesh M Chingle; Dominique L Kunciw; Michael B Yaffe; Terrence R Burke
Journal:  Org Biomol Chem       Date:  2021-09-22       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.